Baxion
Screening
Tags
Alerts
Theme
Immix Biopharma, Inc.
IMMX
·
NASDAQ
·
$8.84
Share Price as of 11/2
·
$481M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
10-Q
Q2 ended 06/30/26
08/07/26
10-Q
Q1 ended 03/31/26
05/07/26
10-K/A
FY 2025
03/27/26
10-K
FY 2025
03/25/26
10-Q
Q3 ended 09/30/25
11/07/25
Disclosures
Filter
8-K
Current report
09/30/26
8-K
Current report
09/29/26
8-K
Current report
07/20/26
8-K
Current report
05/29/26
8-K
Current report
05/21/26
Prospectuses and Registrations
Filter
424B5
Prospectus supplement
09/29/26
FWP
Free writing prospectus
09/29/26
424B5
Prospectus supplement
05/21/26
FWP
Free writing prospectus
05/21/26
424B5
Prospectus supplement
03/25/26
Proxies
Filter
DEF 14A
Definitive proxy
04/06/26
DEFA14A
Additional proxy materials
04/06/26
DEFA14A
Additional proxy materials
05/19/25
DEFA14A
Additional proxy materials
05/05/25
DEF 14A
Definitive proxy
04/30/25
Ownership
Filter
SC 13G
Beneficial ownership
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/13/26
SC 13G/A
Beneficial ownership (amended)
06/05/26
Form 4
Insider transaction
05/29/26
Form 4
Insider transaction
05/29/26
Other
Filter
ARS
Annual report to shareholders
04/06/26
EFFECT
Request for effectiveness
01/22/26
CORRESP
Correspondence with the SEC
01/16/26
UPLOAD
Letter from the SEC
01/16/26
EFFECT
Request for effectiveness
12/01/25
Latest Filings
Filter
8-K
Current report
09/30/26
8-K
Current report
09/29/26
424B5
Prospectus supplement
09/29/26
FWP
Free writing prospectus
09/29/26
10-Q
Q2 ended 06/30/26
08/07/26
Ownership
Filter
SC 13G
Beneficial ownership
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/13/26
SC 13G/A
Beneficial ownership (amended)
06/05/26
Form 4
Insider transaction
05/29/26
Form 4
Insider transaction
05/29/26